WO1999012950A9 - Improvements in or relating to stability of plant starches - Google Patents

Improvements in or relating to stability of plant starches

Info

Publication number
WO1999012950A9
WO1999012950A9 PCT/GB1998/002665 GB9802665W WO9912950A9 WO 1999012950 A9 WO1999012950 A9 WO 1999012950A9 GB 9802665 W GB9802665 W GB 9802665W WO 9912950 A9 WO9912950 A9 WO 9912950A9
Authority
WO
WIPO (PCT)
Prior art keywords
plant
starch
sequence
nucleic acid
isoamylase
Prior art date
Application number
PCT/GB1998/002665
Other languages
French (fr)
Other versions
WO1999012950A3 (en
WO1999012950A2 (en
Inventor
Stephen Alan Jobling
Gerhard Peter Schwall
Roger John Westcott
Original Assignee
Nat Starch Chem Invest
Stephen Alan Jobling
Gerhard Peter Schwall
Roger John Westcott
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Starch Chem Invest, Stephen Alan Jobling, Gerhard Peter Schwall, Roger John Westcott filed Critical Nat Starch Chem Invest
Priority to EP98941593A priority Critical patent/EP1009751A2/en
Priority to CA002302639A priority patent/CA2302639A1/en
Priority to AU89911/98A priority patent/AU8991198A/en
Publication of WO1999012950A2 publication Critical patent/WO1999012950A2/en
Publication of WO1999012950A3 publication Critical patent/WO1999012950A3/en
Publication of WO1999012950A9 publication Critical patent/WO1999012950A9/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/2457Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8245Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified carbohydrate or sugar alcohol metabolism, e.g. starch biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2451Glucanases acting on alpha-1,6-glucosidic bonds
    • C12N9/246Isoamylase (3.2.1.68)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01041Pullulanase (3.2.1.41)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01068Isoamylase (3.2.1.68)

Definitions

  • This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
  • Starch the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin.
  • Amylose is a linear polymer containing ⁇ -1,4 linked glucose units
  • amylopectin is a highly branched polymer consisting of a ⁇ -1,4 linked glucan backbone with ⁇ -1,6 linked glucan branches.
  • amylopectin constitutes about 75% of the starch content.
  • starch synthases which elongate the glucan chains
  • SBE starch branching enzymes
  • Debranching enzymes hydrolyse the c -6-glucosidic linkages of ⁇ -glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and pullulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use pullulan as a substrate.
  • pullulanases EC 3.2.1.41 , which are known in plants as "R- enzymes”
  • amylopectin and pullulan a linear bacterial polymer consisting of 1-6 linked maltotriose units
  • isoamylases EC 3.2.1.68 which act on amylopectin and glycogen but cannot use pullulan as a substrate.
  • a cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants.
  • An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph).
  • the present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
  • the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof.
  • This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention.
  • Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from that shown in Figure 8 by virtue of the degeneracy of the genetic code.
  • a nucleic acid sequence may be altered (e.g.
  • the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above.
  • the construct may typically comprise a selectable marker (e.g. kanamycin or hygromy cm-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention.
  • a selectable marker e.g. kanamycin or hygromy cm-resistance
  • the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
  • Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
  • the introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS type I or patatin promoters of potato.
  • the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs.
  • the operably linked promoter may be tuber-specific, such as the patatin promoter.
  • the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof.
  • the term "functional equivalent” should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
  • the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
  • Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins.
  • the shaded area indicates residues (single letter amino acid code) that are identical to die maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
  • Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 2 and 3) at the 5' and 3.' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
  • Figures 4A and 4B show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
  • Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
  • Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron exon structure, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
  • Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
  • Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of tuber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention.
  • PDBE2 ATC AAA TCT/G A GAA nCC ATC DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
  • Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980).
  • Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCI pH 8.0, 1.4 M NaCI, 10 mM 3-mercaptoethanol and 20 mM EDTA) and incubated at 65°C for 30 min. After cooling, the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature.
  • CTAB cetyltrimethyl ammonium bromide
  • the tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform.
  • the DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 ⁇ g/ml RNase A. After incubation at room temperature for 30 minutes the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/ ⁇ l by fluorometric measurement.
  • oligonucleotide primers were made corresponding to these sequences (DBE2 & DBEl respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
  • Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
  • the exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes.
  • the two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge.
  • Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends
  • Figure 2B shows a comparison of their sequences at the 3' end
  • Figures 3 A and 3B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 134
  • Figures 4A and 4B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 135.
  • two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3' end.
  • Figure 5A shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends.
  • Figures 6 A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133.
  • Figures 7A and 7B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
  • the 0.8 kb clone although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
  • a new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBEl primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase gene.
  • Five ⁇ l of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 ⁇ l PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min).
  • One ⁇ l of this reaction was then used in a second PCR amplification using PIAl and R, primers.
  • a major band of approx 1.5 kb (the expected size) was amplified from both leaf and tuber cDNA templates.
  • the tuber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132).
  • the sequence and predicted ORF of this partial length clone is shown in Figure 8.
  • the ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
  • a plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
  • GBSS granule bound starch synthase
  • a plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as anXba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes.
  • GBSS granule bound starch synthase
  • pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) contaimng a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35.
  • Hz ⁇ dlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the Ht «dIII- EcoRI fragment (contaimng the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39.
  • Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%.
  • Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40 ⁇ E/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness.
  • the protocol for microtuber explants, and that for leaf explants are detailed below.
  • Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days.
  • the feeder layers consisted of a 9cm petri dish containing the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
  • Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after tuber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium.
  • the multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar.
  • Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used.
  • the explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage. Tissue culture and selection using leaf explants was performed as follows.
  • the multiplication medium used contained the salts and vitamins of Murashige and Skoog medium plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin riboside and 0.8% agar. Kanamycin was added at lOOmg/l when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
  • Transformation was confirmed as follows. Shoots which developed from either tuber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone- free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
  • Representative samples of the tubers were stored for analysis and possible regrowth and 150-200g fresh weight was taken for starch extraction.
  • Washed tubers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer.
  • the juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded.
  • the slurry of solids was poured through a 500 ⁇ m metal mesh filter which retained the bulk of the cell debris.
  • the crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid.
  • the starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes.
  • the degree of branching of the starches was determined by 'H NMR spectroscopy (Gidley
  • Example 3 Cloning of a pullulanase type debranching enzyme from potato.
  • a PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l).
  • the amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes.
  • Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the spinach sequence, identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with tuber or leaf first strand cDNA as template.
  • cDNA Five ⁇ l of cDNA was used as template in a 50 ⁇ l PCR reaction with 50 pmol of each degenerate primer (PDBE1 & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds).
  • the PCR products were separated on a 1% agarose gel in TAE buffer.
  • a strong band of the expected size (672bp) was amplified from the tuber cDNA and a much weaker band from the leaf cDNA.
  • the tuber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen).
  • a diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV polyadenylation signal. .. This vector may then be used to transform potato plants, substantially as described in Example 2.
  • zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
  • the debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
  • tuber extracts of ten different antisense lines were analysed in a zymogram as described above.
  • the upper band with a low electrophoretic mobility is a debranching enzyme as it stains blue in the amylopectin containing gel against a purple background.
  • Transformed potato line 1352 clearly lacks this isoamylase band. In this line isoamylase expression was successfully inhibited by the antisense construct.
  • the lower band apparent in Figure 12 is an amylase which stains as a clear zone in a purple background. Depending on incubation time, two additional debranching enzyme bands could be detected which are of the pullulanase type and not affected in line 1352.
  • RVA Rotary Visco Analyser
  • Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
  • Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct.
  • the linear plot shows the temperature profile.
  • a wild type control line 1302, unbroken thin line
  • Starch from line 1352 solid thick curve
  • Starch from line 1352 shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level
  • lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line are slightly increased for line 1352.
  • PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBE1 oligo which was used in the experiments described here.
  • the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined).
  • the inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical ( Figure 4), suggesting that they are derived from different genes.
  • a cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE.
  • the two different isoamylase-type DBE genomic sequences isolated by die inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected to different regulatory controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions.
  • Both pullulanase and isoamylase genes appear to be expressed in tubers and leaves since PCR bands of the correct size can be amplified from either tuber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in tubers for both DBE, possibly indicating that the expression level of both genes is higher in tubers, but this should be confirmed by northern analysis.

Abstract

Disclosed is a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase enzyme gene, together with constructs and host cells comprising the nucleic acid sequence, and methods of using the nucleic acid sequence.

Description

Title : Improvements in or Relating to Stability of Plant Starches
Field of the Invention
This invention relates to novel nucleotide sequences, nucleic acid constructs and host cells and organisms comprising said sequences, methods of altering plants using the sequences, and to products obtainable from the altered plants.
Background of the Invention
Starch, the major storage reserve in plants, consists of two main polysaccharides, amylose and amylopectin. Amylose is a linear polymer containing α-1,4 linked glucose units, while amylopectin is a highly branched polymer consisting of a α-1,4 linked glucan backbone with α-1,6 linked glucan branches. In most plant storage reserves, including tubers, amylopectin constitutes about 75% of the starch content. Until recently it was thought that amylopectin was synthesized by the concerted action of two enzymes: starch synthases, which elongate the glucan chains; and starch branching enzymes (SBE), which introduce branches to create amylopectin. It was further considered that it is the chain length specificity of the branching enzymes that determines the starch structure (Tolmasky & Krisman, 1987). Support for this hypothesis was provided by the characterisation of maize (Takeda et al 1993) and pea SBE (Burton et al 1995).
An alternative hypothesis which is gaining support, suggests that debranching enzymes play an important role in the synthesis of amylopectin and hence starch structure (Ball et al 1996; Nakamura,Y. 1996). The evidence for this comes mainly from an analysis of two mutants: sugary 1 mutants of maize synthesise a highly branched water soluble polysaccharide called phytoglycogen and have a defect in a debranching enzyme (Pan and Nelson 1984; James et al 1995) and a recently characterised mutant (STA7) of Chlamydomonas, which has a dramatic effect on starch synthesis, was shown to have a severe reduction in the activity of a debranching enzyme (Mouille et al 1996). It is desirable to be able to increase the degree of branching and/or reduce the chain length of the amylopectin in starches, especially waxy potato starches, in order to create more freeze/ thaw-stable starches. Very recently, it has been reported that overexpressing the E. coll glycogen branching enzyme in a waxy (i.e. amy lose-free) potato does lead to an increase in the degree of branching of amylopectin (Kortsee et al 1996). However, the increase in branching was only 25 % , and the average chain length of the amylopectin was decreased only marginally - by 3 glucose units (from 25 to 22 glucose residues). An alternative approach to obtain a more highly-modified starch would be to decrease the expression of debranching enzymes in the potato tuber using an antisense or sense- suppression approach. To do this efficiently requires the cloning of a cDNA copy of a potato debranching enzyme.
Debranching enzymes (DBΕ) hydrolyse the c -6-glucosidic linkages of α-glucan polymers and are classified into two types depending on their substrate specificities: (1) pullulanases (EC 3.2.1.41 , which are known in plants as "R- enzymes") which act on amylopectin and pullulan (a linear bacterial polymer consisting of 1-6 linked maltotriose units) but which cannot use glycogen as a substrate; and (2) isoamylases (EC 3.2.1.68) which act on amylopectin and glycogen but cannot use pullulan as a substrate.
Pullulanases have been purified from a number of plants including maize, rice, sorghum, oat, broad bean, potato, sugarbeet and spinach and the corresponding cDNA clones of maize, rice and spinach have been isolated (James et al 1995; Nakamura et al 1996; Renz et al 1995). In potato, both R-enzyme and isoamylase enzyme polypeptides have been characterised and purified (Drummond et al 1970; Ishizaki,Y et al 1983). A recent publication (WO 95/04826) detailed the purification and peptide sequence determination of a pullulanase type DBE. A cDNA encoding a potato DBE was described in a second patent application (WO 96/19581) which detailed the isolation of a partial length (492 bp) cDNA clone encoding a pullulanase type DBE, as well as the effect of downregulating the expression of this gene in transgenic antisense plants. An unspecified number of lines were generated and some showed a decrease in debranching enzyme activity (not quantitated) which also led to a slight modification in the swelling characteristics of the starch as measured by RVA (Rapid Viscoamylograph). These included a decrease in the maximum viscosity to about half of the control, and an increase in the setback viscosity (from 3300 cP in the control to 5200 in the most highly-modified plant line). No significant change in the amylose/amylopectin ratio was observed but there was an increase in the phosphate content of the starch (from 9 to 14.6 nmol G6P/mg starch).
The present application relates particularly to the isolation of nucleic acid sequences encoding potato debranching enzymes (especially isoamylase type debranching enzymes) and to the uses thereof.
Summary of the Invention
In a first aspect the invention provides a nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene. Those skilled in the art will appreciate that the nucleic acid sequence will comprise at least one region which is characteristic of isoamylase-type debranching enzymes and which is not present in pullulanase type debranching enzymes. The nucleic acid sequence will preferably be at least 200bp long, more preferably at least 300-600bp long. Conveniently the sequence is one which is derived or obtained from potato plants.
The nucleic acid sequence of the invention may be, for instance, a genomic sequence, or may be a cDNA sequence. The nucleic acid sequence of the invention may comprise non- coding portions (which are transcribed, but not translated), and/or may comprise coding portions, which are translated into amino acid residues in the full length native gene. As described below, either translated or non-translated portions may be useful in certain techniques, and both therefore possess utility.
In a particular embodiment, the nucleic acid sequence comprises nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8, or a functional equivalent thereof. (This sequence includes a portion encoding the amino acid sequence MDWF/YNH, which portion is typically present in the nucleic acid sequences of the invention). Functionally equivalent nucleic acid sequences include sequences which encode substantially the same polypeptide, but which differ in nucleotide sequence from that shown in Figure 8 by virtue of the degeneracy of the genetic code. For example, a nucleic acid sequence may be altered (e.g. "codon optimised") for expression in a particular host cell or host organism, such that the nucleotide sequence differs substantially whilst the amino acid sequence of the encoded polypeptide is unchanged. Typically, functionally equivalent nucleic acid sequences are those which will hybridise under stringent hybridisation conditions (e.g. as described by Sambrook et al, Molecular Cloning. A Laboratory Manual, CSH, i.e. washing with O. lxSSC, 0.5% SDS at 68 °C) with the sequence shown in Figure 8. Figures_6A-7B illustrate some related sequences, which are also in accordance with the present invention. These are genomic sequences with large stretches of intron sequence, which introns are not represented in mRNA. The sequences illustrated in Figures 6A-7B thus comprise both coding and non-coding portions.
DNA sequences functionally equivalent to that shown in Figure 8 will preferably comprise at least 200, more preferably 300-600bp, and typically will exhibit at least 85% identity (preferably at least 90%, and more preferably at least 95% identity) with the corresponding region of the DNA sequence shown in Figure 8. Those skilled in the art will readily be able to conduct a sequence alignment between the putative functionally equivalent sequence and that detailed in Figure 8 - the identity of the two sequences is to be compared in those regions which are aligned by standard computer software, which aligns corresponding regions of the sequences.
In a second aspect the invention provides a replicable nucleic acid construct comprising the nucleic acid sequence of the first aspect defined above. The construct may typically comprise a selectable marker (e.g. kanamycin or hygromy cm-resistance) and may allow for transcription (and possibly translation) of the nucleic acid sequence of the invention. Conveniently therefore the construct will comprise a promoter (especially a promoter sequence operable in a plant and/or a promoter operable in a bacterial cell), and one or more regulatory signals (such as polyadenylation signals) known to those skilled in the art.
The nucleic acid sequence of the invention can be introduced into plants which express a homologous sequence encoding an isoamylase enzyme, in such a way that the introduced sequence interferes with the expression of the homologous sequence. Thus, for example, the nucleic acid sequence of the invention may be operably linked in the antisense orientation to a suitable promoter active in the plant into which the sequence is to be introduced, so as to reduce the levels of expression of the homologous isoamylase enzyme present in the plant.
Additionally, it has recently been demonstrated in other experimental systems that "sense suppression" can also occur (i.e. expression of an introduced sequence operably linked in the sense orientation can interfere, by some unknown mechanism, with the expression of the homologous, native gene), as described by Matzke & Matzke (1995 Plant Physiol. 107, 679-685). Any one of the methods mentioned by Matzke & Matzke could, in theory, be used to affect the expression in a host of a homologous isoamylase gene.
It has been found in some experimental systems that there is no requirement for translation of the introduced sequence in order for an inhibitory effect to be observed, and it is believed that antisense methods are mainly operable by the production of antisense mRNA which hybridises to the sense mRNA, preventing its translation into functional polypeptide, possibly by causing the hybrid RNA to be degraded (e.g. Sheehy et al, 1988 PNAS 85, 8805-8809; Van der Krol et al, Mol. Gen. Genet. 220, 204-212). Sense suppression also requires homology between the introduced sequence and the target gene, but the exact mechanism is unclear. It is apparent that, in relation to both antisense and sense suppression, neither a full length nucleotide sequence, nor a "native" sequence (i.e. the introduced sequence need not be 100% identical to the sequence of the homologous native gene) is essential. Preferably the nucleic acid used will comprise at least 300-600bp of sequence, but by simple trial and error other fragments (smaller or larger) may be found which are functional in altering the characteristics of the plant.
Accordingly, in a third aspect the invention provides a method of altering a plant by inhibiting the expression of an isoamylase gene therein, the method comprising introducing into the plant the nucleic acid sequence of the invention, operably linked (in the sense or anti-sense orientation) to a promoter active in the plant, wherein the isoamylase gene in the plant has homology to the introduced sequence. The introduced nucleic acid will typically comprise at least 200bp, more preferably 300-600bp of sequence having at least 80% (advantageously at least 85%, desirably over 90%) sequence identity with the native isoamylase gene(s) present in the plant.
Advantageously the plant will be a plant which normally comprises large amounts of starch, such as potato, sweet potato, maize, wheat, barley, oat. cassava, pea, rice and the like. It is probable that the greater the homology between the introduced sequence and the native gene, the greater the inhibition of expression of the native gene. Preferably the plant is therefore a potato plant, and/or a plant which has a reduced amylose content (e.g. the "waxy" mutation of potato or the "LAM" [low amylose mutant] strain of pea).
Inhibition of the isoamylase gene might be expected to affect the properties of the starch present in the plant. In particular it might be expected to result in a starch having increased branching and/or shorter chain length. The obtaining of starch having such properties is a particular object of the present invention.
It may also be advantageous to introduce into the plant one or more additional nucleic acid sequences, especially sequences which might also be expected to have an effect on synthesis and/or metabolism of starch in the plant. Particularly preferred are sequences which inhibit the expression of a pullulanase debranching enzyme in the plant. Plant pullulanase sequences are known to those skilled in the art (e.g. WO 96/19581), and a portion of a potato pullulanase cDNA sequence is also disclosed herein. The additional nucleic acid sequence will typically be homologous to a portion of a native gene in the plant and, as described above, may be introduced into the plant operably linked to a suitable promoter in either the sense or the anti-sense orientation.
The introduced sequence of the invention and the one or more additional sequences may be operably linked to a single promoter (which would ensure both sequences were transcribed at essentially the same time), or may be operably linked to separate promoters (which may be necessary for optimal expression). Where separate promoters are employed they may be identical to each other or different. Suitable promoters are well known to those skilled in the art and include both constitutive and inducible types. Examples include the CaMV 35S promoter (e.g. single or tandem repeat) and the GBSS type I or patatin promoters of potato. Advantageously the promoter will be tissue-specific. Desirably the promoter will cause expression of the operably linked sequence at substantial levels only in the tissue of the plant where starch synthesis and/or starch storage mainly occurs. Thus, for example, where the sequence is introduced into a potato plant, the operably linked promoter may be tuber-specific, such as the patatin promoter.
Those skilled in the art will also appreciate that, if additional nucleic acid sequences are to be introduced into the plant, they may be present on the same nucleic acid plant transformation vector as the portion of isoamylase-encoding sequence, or may be introduced on separate vectors (for example by re-transformation). The sequence of the invention, and the one or more additional sequences if desired, can be introduced into the plant by any one of a number of well-known techniques (e.g. Agrobacterium-mediated transformation, or by "biolistic" methods).
In another aspect, the invention provides a plant cell, or a plant or the progeny thereof, which has been altered by the method defined above. Altered plant cells, into which the sequence of the invention has been introduced, may be grown into plantlets by conventional methods well-known to those skilled in the art. The progeny of an altered plant may be obtained, for example, by vegetative propagation, or by crossing the altered plant and reserving the seed so obtained. The invention also provides parts of the altered plant, such as storage organs. Conveniently, for example, the invention provides tubers comprising altered starch, said tubers being obtained from an altered plant or the progeny thereof.
The invention also provides a method of obtaimng starch from an altered plant, the plant being obtained by the method defined above. Starch may be extracted from the plant by any of the known techniques (e.g. milling). The invention further provides starch obtainable from a plant altered by the method defined above, the starch having altered properties compared to starch extracted from an equivalent but unaltered plant. Conveniently the altered starch is obtained from an altered plant selected from the group consisting of cassava, potato, pea, tomato, maize, wheat, barley, oat, sweet potato and rice. Typically the altered starch will have an increased degree of branching and/or reduced amylopectin chain length, compared to starch extracted from an equivalent but unaltered plant. In general, such altered starch obtained by means of the present invention is found to possess different viscosity charcteristics compared to starch extracted from equivalent, but unaltered, plants. In particular, the inventors have found that starch obtained from plants altered by the method of the invention may have reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument, (available from Newport Scientific, Sydney, Australia) according to the manufacturer's standard stirring and heating protocol. Alternatively, or additionally, the altered starch may have higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, (as determined, for example, by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument). Further, the altered starch may have an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, (as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument).
The terms "peak viscosity", "setback viscosity" and "viscosity onset temperature" are well known and understood by the person skilled in the art. By way of explanation for the novice reader, the viscosity of starch preparations is generally investigated by heating an aqueous sample of the starch under controlled conditions of temperature increase, temperature maintenance, and subsequent temperature decrease and with controlled stirring, using an instrument known as a Visco analyser, which produces a viscosity profile called a "viscoamylograph". The "peak viscosity" is the maximum viscosity which is attained during the temperature increase phase. The "setback viscosity" is the viscosity obtained at the end of the viscoamylograph. The viscosity onset temperature is the temperature at which a sudden increase of viscosity is apparent on the viscoamylograph.
For the purposes of the present invention, an "equivalent, but unaltered" plant may be considered as a plant which has a substantially identical genotype to a plant altered by the method of the invention, except for the introduced sequences present in the altered plant of the invention. Also to be considered as an equivalent but unaltered plant are those plants which comprise the introduced sequence but wherein the introduced sequence has not affected the starch properties of the plant.
In a further aspect, the invention provides a nucleic acid sequence encoding at least a portion of a potato pullulanase type debranching enzyme, the sequence comprising substantially nucleotides 46-774 of the nucleic acid sequence shown in Figure 10, or a functional equivalent thereof. The term "functional equivalent" should be interpreted as explained previously, but with reference (in this aspect of the invention) to Figure 10 rather than Figure 8.
Similarly, the invention provides nucleic acid constructs, and altered host plant cells and organisms, comprising the pullulanase-type DBE nucleic acid sequence defined immediately above.
The invention will now be further described by way of illustrative example and with reference to the accompanying drawings, in which:
Figure 1 shows a comparison of the known amino acid sequences of various putative isoamylase proteins. The shaded area indicates residues (single letter amino acid code) that are identical to die maize protein. Dashes indicate gaps introduced to maximise the alignment. Although the whole sequences were compared, only the most conserved region is shown. Sequences are identified at the right; A10906_l is an artificial sequence, A37035 is from a Pseudomonas species SMP1, HIU32761 is from Haemophilus influenzae, ISOA_PSESP is from Pseudomonas amylodermosa and ZMU18908_1 is from Zea mays (corn);
Figures 2A and 2B show a comparison of the 5' and 3' ends (respectively) of two partial pullulanase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 3A and 3B show the DNA sequence (SEQ. ID. NO.s 1 and 4 respectively) and predicted intron/exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 2 and 3) at the 5' and 3.' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 4A and 4B show the DNA sequence (SEQ. ID. NO.s 5 and 8 respectively) and predicted intron exon structure, including predicted amino acid sequences (SEQ. ID. NO.s 6 and 7) at the 5' and 3' ends respectively of a partial pullulanase type DBE genomic clone (certain restriction sites are also marked);
Figures 5 A and 5B show a comparison of the 5' and 3' ends (respectively) of two partial isoamylase type DBE genomic clones recovered from potato by the present inventors (nucleotides that are identical are shown between the two sequences and dashes indicate gaps introduced to optimise the alignment);
Figures 6 A and 6B show the DNA sequence (SEQ. ID. NO.s 9 and 11 respectively) and predicted intron exon structure, including predicted amino acid sequence (SEQ. ID. NO. 10) at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figures 7 A and 7B show die DNA sequence (SEQ. ID. NO.s 12 and 13 respectively) and predicted intron/exon structure at the 5' and 3' ends respectively of a partial isoamylase type DBE genomic clone (certain restriction sites are also marked);
Figure 8 shows the DNA sequence (SEQ. ID. NO. 14), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 15) of a partial length potato debranching enzyme (isoamylase) cDNA clone (pSJ132, described below); nucleotides 79-1595, including the poly(A) tail, are isoamylase, the other sequence is derived from pT7Blue vector;
Figure 9 is a schematic representation of the plant transformation vector pSJ138;
Figure 10 shows the DNA sequence (SEQ. ID. NO. 16), restriction map and predicted open reading frame (including predicted amino acid sequence, SEQ. ID. NO. 17) of a pullulanase type partial length potato debranching enzyme cDNA clone (pSJ98, described below); nucleotides 46-774 are DBE, the other sequence is derived from pT7Blue vector;
Figure 11 is a schematic representation of a "double" plant transformation vector, comprising partial isoamylase- and pullulanase-type debranching enzyme sequences operably linked in me anti-sense orientation to separate GBSS promoters;
Figure 12 shows a zymogram (using a 5% polyacrylamide gel containing 1 % amylopectin) of tuber extracts from potato lines transformed with an antisense isoamylase construct in accordance with the invention; and
Figure 13 shows viscosity (RVA) profiles of starch from potato lines transformed with an antisense isoamylase construct, and from a wild type control (1302).
EXAMPLES
Example 1 : Isolation of a partial cDNA clone of a potato isoamylase.
Throughout the examples described in the present specification, standard procedures were performed essentially according to Sambrook et al (1989). DNA sequencing was performed on an ABI automated DNA sequencer and sequences manipulated using DNASTAR software for the Macintosh computer.
Oligonucleotides
The following oligonucleotides (SEQ ID. NO.s 18-29 respectively) were employed in the examples described below:
RoRidTI7 AAG GAT CCG TCG ACA TCG ATA ATA CGA CTC ACT ATA GGGA(T17)
Ro AAG GAT CCG TCG ACA TC
Ri GAC ATC GAT AAT ACG AC
PDBE1 GAC/T GAC/T GTn AAA/G CCT GAA G GG
PDBE2 ATC AAA TCT/G A GAA nCC ATC DBE1 ATG GAT GTT GT(T/C/A) TA/TC/T AAT/C CAT
DBE2 TCA AAA/T CG/TA/G AAi CCA TC
PIA1 GAG GCA TTG ACA ACA GTG TG
PIA2 CGT GAC ATG GTA CGG CAG TT
PIA3 AAC TGC CGT ACC ATG TCA CG
PIA4 GGT TAT AGA TGG CAG CCG TT
PIA5 AAC GGC TGC CAT CTA TAA CC
Potato DNA isolation
Genomic DNA was isolated from potato leaves using a modified CTAB (cetyltrimethyl ammonium bromide) method (Murray and Thompson, 1980). Leaf tissue (4 gm) was frozen in liquid nitrogen and ground in a mortar and pestle and transferred to a 50 ml polypropylene centrifuge tube (Falcon) to which was added 40 ml of extraction buffer ( 2% w/v CTAB, 100 mM Tris-HCI pH 8.0, 1.4 M NaCI, 10 mM 3-mercaptoethanol and 20 mM EDTA) and incubated at 65°C for 30 min. After cooling, the mixture was split into two tubes and 15 ml of chloroform was added to each followed by gentle (end over end) mixing for 15 min at room temperature. The tubes were then centrifuged for 5 min at 5000g and the pooled aqueous phases were re-extracted with 5 ml of chloroform. The DNA was then precipitated by incubating on ice for 30 minutes with an equal volume of isopropanol and centrifuged for 5 minutes at 3000g. The pellet was washed once with 70% ethanol, briefly air-dried and resuspended in TE pH 8.0 containing 20 μg/ml RNase A. After incubation at room temperature for 30 minutes the DNA was extracted with 5ml of chloroform, one tenth volume of 3 M sodium acetate (NaAc) pH 5.2 was added and the DNA precipitated with two volumes of ethanol. After centrifugation and washing as above, the DNA was resuspended in 2 ml of TE buffer at pH 8.0 and estimated to be approximately 150 ng/μl by fluorometric measurement.
RNA isolation and cDNA synthesis
RNA was isolated from potato plants by the method of Logemann et al (1987). Tuber material consisted of small tubers (<1 gm ) harvested from a mature plant. Leaf material was from source leaves (>10 cm) of a healthy vigorously growing plant from the greenhouse. Five microgram of RNA was heated in water for 3 minutes at 65°C and then reverse transcribed in a 50 μl reaction using 10 pmol of RoRidT17 as primer and MMLV reverse transcriptase (Stratascript 50 units; reaction conditions 50mM Tris-HCI (pH 8. 3), 75mM KC1, lOmM DTT, 3mM MgCl2, 0.5mM each dNTP, lU/μl RNasin and incubation for 1 hour at 37°C). The reaction was then diluted to 200 μl with TE pH 8.0 and stored at 4°C.
Isoamylase cloning
No amino acid sequence information for isoamylase enzymes from potato was publicly available at the time this work was performed, therefore the cloning strategy relied only on conserved sequence regions among known or putative isoamylase type debranching enzymes from other sources. As shown in Figure 1, there are two regions within isoamylase proteins that are conserved. One of these is the same DGFRFD sequence found in the pullulanase enzymes (see example 3) and the second (MDVNF YNH) is found approx 70 aa from this sequence towards the N-terminus. Degenerate oligonucleotide primers were made corresponding to these sequences (DBE2 & DBEl respectively, see above), taking into consideration the codon usage in plant genes in order to reduce the degeneracy of the primers. These were used in a PCR reaction using first strand cDNA from leaf or tuber RNA or genomic DNA as template.
Approximately 50ng of potato genomic DNA or 5μl of first strand cDNA were used as template in a 50μl PCR reaction containing 25pmol of each degenerate primer (DBEl & 2) under standard PCR conditions (30 cycles of 94°C 60 seconds, 50°C 60 seconds, 72°C 60 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. The expected size fragment (240 bp) was amplified from both leaf and tuber cDNA templates although the signal was stronger in the latter. However when genomic DNA was used as template, 5 strong bands of approx 2.4, 2.0, 1.8, 1.6 and 0.6 kb were amplified indicating that intron(s) are present within this portion of the genes. This pattern was very reproducible and only occurred when both primers were used in the PCR reaction. These 5 bands were cut out and purified using Qiaquick columns (Qiagen) and then cloned in the pT7Blue vector (Novagen).
Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. One clone of each of the 5 PCR fragments was sequenced from either end and in one direction only, therefore the sequence cannot be guaranteed 100 % correct.
The exon sequences of the 1.8 and 1.6 kb bands (clones #43 & #34, designated pSJ134 and pSJ135 respectively) were found to be identical to pSJ98 (a pullulanase type DBE partial clone, described below) indicating that they are pullulanase type debranching enzymes. The two clones pSJ134 and pSJ135 are not identical, sharing 96.3% identity over the entire sequence at the 5' end, and 89.8% identity over 160 nucleotides at the 3' end, after which the two sequences diverge. Figure 2 A shows a comparison of the sequences of clones 134 and 135 at their 5' ends, whilst Figure 2B shows a comparison of their sequences at the 3' end. Figures 3 A and 3B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 134. Similarly, Figures 4A and 4B illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 135. In both clones, at the 5' end two exons can be distinguished, separated by a 101 bp intron and the remainder of the exon sequences are present in the 3' end.
The 2.4 and 2.0 kb bands (clones #44 & #42, designated pSJ133 and pSJ137 respectively) showed most homology to the isoamylase genes (data not shown). Figure 5A shows a comparison of the 5' ends of these clones, whilst Figure 5B compares their 3' ends. As with the pullulanase clones, clones 133 and 137 were not identical (96 and 97% identity at the 5' and 3' ends respectively). Figures 6 A and 6B illustrate the presumed intron/exon structure of the 5' and 3' ends (respectively) of clone 133. Similarly, Figures 7A and 7B . illustrate the presumed intron/exon structure of the 5' and 3' ends respectively of clone 137. Only one intron can be distinguished at each end.
The 0.8 kb clone, although it had the correct primers on both ends was not a debranching enzyme but had homology to a rice Expressed Sequence Tag (RICR2232A) which encodes a 70kDa endomembrane protein.
A new sense primer (PIAl) was designed to the isoamylase sequences just downstream of the DBEl primer and this was use in a 3 'RACE PCR to clone the 3' end of the isoamylase gene. Five μl of first strand cDNA and 25 pmol of each primer (PIAl and Ro) were used in a 50 μl PCR reaction (94°C 2 min followed by 30 cycles of 94°C 45 seconds, 55°C 25 seconds, 72°C 2 min). One μl of this reaction was then used in a second PCR amplification using PIAl and R, primers. A major band of approx 1.5 kb (the expected size) was amplified from both leaf and tuber cDNA templates. The tuber PCR fragment was purified on a 1% TAE agarose gel and then cloned in pT7Blue (clone designated pSJ132). The sequence and predicted ORF of this partial length clone is shown in Figure 8. The ORF contains 429 aa and is 77.0% identical to the maize isoamylase protein encoded by the sugary- 1 gene (data not shown).
Example 2: Transformation of plants with antisense isoamylase
A plant transformation vector with the hygromycin selectable marker was constructed in which the 1.5 kb isoamylase cDNA from plasmid pSJ132 was inserted in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter. This vector (pSJ138) was then used to transform wild type and waxy potato plants.
Construction of plant transformation vector
A plant transformation vector (pSJ138) was constructed by inserting the 1.5 kb isoamylase cDNA from plasmid pSJ132 (as anXba l-Sac I fragment) in an antisense orientation under the control of the granule bound starch synthase (GBSS) promoter into the plant transformation vector pSJ39 which had been cut with the same enzymes. pSJ39 is a modified GPTV-HYG vector (Becker et al 1992) contaimng a 0.8 kb GBSS promoter and was constructed as follows: first the BamHI site between the hygromycin selectable marker and the gene 7 polyadenylation signal in pGPTV-HYG was destroyed by cutting and filling in with klenow polymerase to create pSJ35. The HzΗdlll-EcoRI fragment of this vector (containing the GUS gene & nos polyadenylation signal) was replaced with the Ht«dIII- EcoRI fragment (contaimng the GBSS promoter-GUS-nos poly(A) cassette) from plasmid pGB121 (obtained from R Visser, Wageningen) to create plasmid pSJ39. Plasmid pGB121 was constructed by inserting the 0.8 kb GBSS promoter from genomic clone LGBSSwt-6 (Visser et al 1989) as an Hindlll-Nsil (klenow filled in) fragment into the H dIII-ΛtI(T4 DNA polymerase blunted) sites of plasmid pBI121 (Jefferson et al 1987). Construction of pSJ138 is illustrated schematically in Figure 9. In Figure 9 the black line represents the DNA sequence. The hashed line represents the bacterial plasmid backbone (containing the origin of replication and bacterial selection marker) and is not shown in full. The filled triangles represent the T-DNA borders (RB = right border and LB = left border). Relevant restriction enzyme sites are shown above the black line with the approximate distances (in kilobases kb) between sites marked by an asterisk shown underneath. The thinnest arrows represent polyadenylation signals (pA-nos = nopaline synthase, pAg7 = Agrobacterium gene 7), the intermediate arrows denote protein coding regions (HYG = hyromcin resistance gene etc) and the thick arrows indicate promoter regions (P-GBSS = granule bound starch synthase and P-nos = nopaline synthase).
Potato transformation protocol
Transformed potato plants cv Desiree were produced by co-cultivation of explants with Agrobacterium tumefaciens LBA 4404 containing plant transformation vector plasmids. Two explant types were used, microtubers and leaf fragments, both produced from stock cultures, requiring different methods in culture. Stocks of plantlets were maintained of wild type untransformed Desiree or selected lines previously transformed with antisense genes coding for enzymes of the starch biosynthetic pathway by regular transfer of single node explants using Murashige and Skoog media (1962 Physiol. Plant 15, 473) solidified with 0.8% agar with the sucrose concentration reduced from 3% to 1%. Microtuber explants were produced by transferring nodes to the same medium with the sucrose concentration increased to 8% plus the addition of 2.5mg/l benzylaminopurine. All cultures were grown at 22°C with illumination from fluorescent tubes at 40μE/sqm for 16 hours, except those cltures grown to produce microtubers, which were kept in darkness. The protocol for microtuber explants, and that for leaf explants (based ona modification of that published by Rocha-Sosa et al 1989, EMBO J. 8, 23), are detailed below.
Explants were initially precultured on the appropriate multiplication medium for two days before co-cultivation. Co-cultivation was for 10 minutes in an overnight culture of the Agrobacterium before explants were blotted on filter paper to remove excess bacteria. After blotting explants were transferred to filter paper on feeder layers and incubated in darkness at 22°C for two days. The feeder layers consisted of a 9cm petri dish containing the appropriate multiplication media covered by 2ml of stationary phase tobacco suspension culture cells which were in turn covered by two layers filter paper.
After two days the explants were removed and washed in Murashige and Skoog medium (without sucrose or agar) containing 500μg/ml cefataxime, blotted on filter paper and transferred to multiplication medium containing 500μg/ml cefataxime. After a further five days the explants were further transferred to the same medium containing the selection agent. Selection was effected by the use of the NPTII gene in the construct and addition of kanamycin in the tissue culture process or the HPTII gene with additions of hygromycin. To achieve double transformations lines resistant to kanamycin containing the NPTII gene and a gene to modulate starch biosynthesis were subsequently transformed with a construct containing the HPTII using hygromycin selection. This was reversed if the line used had been originally transformed with a HPTII containing construct and NPTII and kanamycin were used for selection.
Tissue culture and selection using microtuber explants was performed as follows. Microtubers were taken from stock when they were sufficiently large and mature to use. This occurred after 6-8 weeks from transfer of nodes to the high sucrose medium when they weighed more than 30mg and had started to turn from white to pink. Stocks were used for several months after tuber initiation provided they remained dormant and no new shoots or stolons had emerged from the bud end. Each tuber was cut in half longitudinally through the terminal bud and the cut end put in contact with the medium. The multiplication medium (Z5) used contained the salts and vitamins of Murashige and Skoog plus 3% sucrose, 0.2mg/l indole acetic acid, 5 mg/1 zeatin and 0.8% agar. Kanamycin was added at lOOmg/1 when NPTII was used and hygromycin at 15mg/l when HPTII was used. The explants were transferred to fresh medium every two weeks. Explants had two transfers on medium Z5, followed by one transfer on the same medium, except indole acetic acid and zeatin were replaced by lOmg/1 of gibberellic acid (medium MSG). At each transfer all shoots were removed and discarded. The final transfer was to hormone- free Murashige and Skoog medium with the sucrose concentration reduced from 3% to 1%. Shoots were allowed to develop at this stage. Tissue culture and selection using leaf explants was performed as follows. Expanded leaves were taken from stock cultures and cut into fragments comprising a half or a third of the leaf. The multiplication medium used contained the salts and vitamins of Murashige and Skoog medium plus 1.6% glucose, 0.02 mg/1 naphthyl acetic acid, 2mg/l zeatin riboside and 0.8% agar. Kanamycin was added at lOOmg/l when NPTII was used and hygromycin at 5mg/l when HPTII was used. Cultures were transferred every two weeks to the same medium. After four transfers the cultures which were vitrified or showed poor shoot development were transferred to liquid Murashige and Skoog medium containing 1.6% sucrose only.
Transformation was confirmed as follows. Shoots which developed from either tuber of leaf explants after the multiplication/organogenesis phase were transferred individually to hormone- free Murashige and Skoog medium containing 1% sucrose and 100 mg/1 kanamycin or 15mg/l hygromycin depending on the selection which was used. Only one shoot was taken from each explant unless the origin of separate shoots were well separated on the explant. Shoots which rooted on selection within two weeks were transferred to the same medium without selection and given an identifying number. When growth allowed sufficient tissue to be sampled, DNA was extracted from a few mgs of leaf and stem tissue of the culture using the method published by Edwards et al (1991 Nucleic Acids Research 19,(6) 1349) and transformation was confirmed by PCR using gene specific primers. Material was left in culture to allow individual shoots to be micropropagated. Positive shoots were micropropagated to be stored in vitro and also to provide planting material.
Growth of Transformed Lines
Five plants from each line, when 50- 100mm high, were transferred to compost made up of 50%) horticultural sand and 50% Levington F2 peat-based compost in 20mm square modular pots and maintained at 20°C (day) and 15°C (night) in a growth room illuminated for 16 hours with high pressure sodium lamps at an illumination of 400 μE/sq m. After watering they were covered within a small propagator and shaded from illumination. After 7-10 days when new growth was apparent the shading was removed and the plants grown on, with an intermediate potting to 70mm diameter pots. Finally the five plants were grown to maturity together in a 250mm diameter pot in Levington F2 compost under glass. Sixteen to eighteen weeks after transfer from culture when the foliage began to die down all the tubers were harvested.
Representative samples of the tubers were stored for analysis and possible regrowth and 150-200g fresh weight was taken for starch extraction.
Starch extraction
Washed tubers were diced and homogenised to a juice by passage through a Braun MP 75 centrifugal juicer. The juice was diluted with tap water to a volume of approximately 3L in a 5L conical flask. After 30 minutes the unsedimented supernatant liquid was discarded and the remaining solids washed again with a further 3L of water. After a further 30 minutes the liquid was decanted and discarded. The slurry of solids was poured through a 500μm metal mesh filter which retained the bulk of the cell debris. The crude starch which passed through the filter was washed in the same manner until no protein foam remained and only white starch settled on the base of the flask below a clear supernatant liquid. The starch was harvested on filter paper using a Buchner funnel and washed on the funnel with two 500ml volumes of distiled water. Finally the starch was washed with 500ml of acetone and dried in a fume hood for approximately 30 minutes.
Starch analysis
The degree of branching of the starches was determined by 'H NMR spectroscopy (Gidley
1985), and more detailed analysis performed as dscribed in example 5 below.
Example 3: Cloning of a pullulanase type debranching enzyme from potato.
A PCR based cloning strategy was devised for isolating pullulanase type debranching enzymes from potato, using conserved domains within the known cloned gene sequences, of which spinach was the only plant gene (genbank SOPULSPO_l). The amino acid sequence DGFRFDLMG was almost completely conserved (data not shown) and this is found at aa 546-554 of the spinach protein (964 aa in total). It was hoped therefore that this would also be present in the potato gene, as the sequence DGFRFD is also completely conserved in plant starch branching enzyme genes which belong to the same superfamily of amylolytic genes. Peptide sequences from the purified potato debranching enzyme which were published in WO 95/04826 were also compared to the spinach sequence; of the 12 peptide sequences 10 made possible matches to the spinach sequence and of these peptide number 1 (RTLLVNLDSDDVKPEGGDNL. corresponding to aa 300-319 of the spinach sequence, identical residues underlined) was chosen to make a degenerate oligonucleotide sense primer (PDBEl;20mer,64x) to be used in PCR with a degenerate antisense primer designed to the sequence DGFRFD (PDBE2; 18mer, 16x). These primers were used in a PCR reaction with tuber or leaf first strand cDNA as template.
Five μl of cDNA was used as template in a 50 μl PCR reaction with 50 pmol of each degenerate primer (PDBE1 & 2) under standard PCR conditions (28 cycles of 94°C 45 seconds, 48°C 25 seconds, 72°C 90 seconds). The PCR products were separated on a 1% agarose gel in TAE buffer. A strong band of the expected size (672bp) was amplified from the tuber cDNA and a much weaker band from the leaf cDNA. The tuber amplified band was cut out and purified by binding to DEAE paper and then cloned in the pT7Blue vector (Novagen). Colonies were screened by PCR and positives were grown up and DNA isolated from a 50 ml culture by alkaline lysis and PEG precipitation. The resulting plasmid was designated pSJ98 and the sequence is shown in Figure 10. Comparison of this sequence to the spinach gene showed it to be 75.7% identical at the DNA level and 75.5 % at the protein (data not shown). It is concluded therefore that this gene belongs to the pullulanase class of debranching enzymes. In all, three clones of the potato DBE PCR in pT7Blue were sequenced (#4, 5 & 6) #4 = pSJ98, #5 = pSJ136 opposite orientation (17305-506). Clone #6 was found to have a 34bp deletion approx 100 bp from the 5' end, which caused a shift in the reading frame resulting in a truncated polypeptide.
Example 4 Construction of double antisense isoamylase and pullulanase plant transformation vector
A cassette consisting of the 0.7 kb pullulanase type DBE cDNA from pSJ98 in an antisense orientation between the GBSS promoter and CaMN poly A signal (Guerineau et al 1988), was inserted as a blunt fragment into the unique Pme I site of the plant transformation vector pSJ138. A diagram of the resulting vector is shown in Figure 11. In Figure 11, the symbols used have the same meanings as in Figure 9: pA-CaMV is the CaMV polyadenylation signal. .. This vector may then be used to transform potato plants, substantially as described in Example 2.
Example 5 Analysis of potato plants transformed with Isoamylase antisense construct (from example 2)
Zymograms
There is no specific assay for debranching enzymes. Therefore zymograms are usually used to determine the presence or absence of debranching enzymes. Protein extracts were separated on native 5% polyacrylamide gels containing 1% potato amylopectin. After separation the gel was incubated for 1-3 hours in 100 mM citrate buffer pH 5.5 containing 10 mM EDTA, 1 mM acarbose, and 2.5 mM DTT. The gel was then rinsed twice in deionized water and stained with iodine (Lugol's solution). Debranching enzymes stain as blue bands against a purple background, whereas amylases appear as clear bands.
In order to distinguish between the two classes of debranching enzymes, isoamylases and pullulanases, a second set of protein extracts was separated on another polyacrylamide gel containing 1% amylopectin. After the run the proteins were transferred onto a 10% polyacrylamide gel containing 1% red pullulan (Megazyme, Wicklow, Ireland) using standard Western blotting apparatus. The red pullulan containing gel was then incubated as described above for the amylopectin containing gel. Pullulanase bands appear as clear bands against the red background. The debranching enzyme bands in the amylopectin gel can thus be classified into isoamylase bands (which do not appear in the red pullulan containing gel) and pullulanase bands (which give clear bands in red pullulan containing gels).
In Figure 12 tuber extracts of ten different antisense lines were analysed in a zymogram as described above. The upper band with a low electrophoretic mobility is a debranching enzyme as it stains blue in the amylopectin containing gel against a purple background. By comparison with the band pattern of a red pullulan containing gel (data not shown) it could be demonstrated that this band is not a pullulanase and can therefore be classified as an isoamylase. Transformed potato line 1352 clearly lacks this isoamylase band. In this line isoamylase expression was successfully inhibited by the antisense construct. The lower band apparent in Figure 12 is an amylase which stains as a clear zone in a purple background. Depending on incubation time, two additional debranching enzyme bands could be detected which are of the pullulanase type and not affected in line 1352.
Analysis of starch by RVA (Rapid Visco Analyser)
In addition to the examination of isoamylase enzyme expression by zymograms, the physical properties of tuber starch was analysed, in order to test whether the lack of the isoamylase enzyme alters the starch properties.
Viscosity development of starches was analysed using a Rapid Visco Analyser Series 4 instrument (Newport Scientific, Sydney, Australia). For the 13 minute profile, 2 g of starch was weighed into a sample cup and 25 ml of water was added to give a final starch concentration of 7.4 % (w/v) and the analysis was performed using the standard stirring and heating protocol according to the manufacturer's instructions. Viscosity was measured in centipoise (cP).
Figure 13 shows the viscosity profiles of tuber starches from plants transformed with the antisense isoamylase construct. The linear plot shows the temperature profile. In addition a wild type control (line 1302, unbroken thin line) is shown. Starch from line 1352 (solid thick curve) shows a clearly reduced peak viscosity and a significantly higher setback viscosity compared to the wild type control (1302) and starches of transformed plants with no change in isoamylase expression level (lines 1328 - thin dotted curve; 1365 - thin dotted/dashed line; and 1369 - thin dashed line). In addition the viscosity onset temperature (pasting temperature) is slightly increased for line 1352. These data clearly indicate that the reduction of isoamylase activity (in line 1352) changes the starch structure and composition resulting in novel physico-chemical properties.
Discussion
When this work was started, no cDNA clones of potato debranching enzymes had been reported although some peptide sequences from a purified potato pullulanase were published in patent WO 95/04826. The present inventors were able to clone a partial length (672 bp) cDNA .clone of a potato pullulanase (pSJ98, Figure 10). A second publication (WO 96/19581) by the authors of WO 95/04826 then described the cloning of a full length cDNA of a spinach DBE (pullulanase type) as well as a PCR fragment of a potato pullulanase. The latter PCR fragment (492 bp) was isolated using primers derived from the sequence of a genomic clone which hybridised to a degenerate oligonucleotide very similar to the PDBE1 oligo which was used in the experiments described here. However the deduced amino acid sequence of the PCR fragment did not correspond exactly to the two peptide sequences from the purified protein (RTLLVNLDSDDVKPEGGDNL, SEQ. ID. NO. 30; and RLSSAGITHVHLLPTYNFA, SEQ. ID. NO. 31; differences are shown underlined). The authors of WO 96/19581 concluded that this was a result of the protein being purified from the variety Desiree whereas the cDNA library was constructed from the variety Berolina. However, the peptide sequences also do not match exactly the sequence of pSJ98 (which was isolated from Desiree) suggesting that more than one pullulanase type DBE gene exists in potato. This is supported by the comparison the of the two PCR fragments which show only 93.6% identity at the DNA and 90.7% at the protein level with one amino acid insertion in the prior art clone (data not shown).
Further evidence that more than one pullulanase gene exists was provided by the cloning of two PCR fragments (1.8 and 1.6 kb) from genomic DNA (pSJ134 & 135). Sequence obtained from the ends of the clones indicated that they differed in the size of one intron (compare Figures 3A/B and 4A/B). The exon sequence of clone pSJ134 was identical to pSJ98 at the amino acid level but those of pSJ135 differed at one amino acid (results not shown).
The inventors have also cloned two PCR fragments (2.4 and 2.0 kb; pSJ133 and 137 respectively) from genomic DNA of potato which have significant homology to isoamylase genes. These clones differ in the size, and perhaps number, of introns and are about 96-97% identical (Figure 4), suggesting that they are derived from different genes. A cDNA fragment of approx 1500 bp was obtained by 3 'RACE; this cDNA encodes 429 aa which are 77% identical to the maize isoamylase gene and the inventors are confident that this gene is an isoamylase type DBE. It is possible that the two different isoamylase-type DBE genomic sequences isolated by die inventors relate to two different genes having slightly different functions or roles in the potato plant, and that similar multiple isoamylase-type genes exist in other plants. Different isoamylase-type genes might, for instance, be subjected to different regulatory controls. As the genomic sequences recovered are not full length genes, it is possible that the respective gene sequences may diverge in the uncloned portions. It may therefore be desirable to ensure that, in the various methods of the invention defined previously, a single sequence is used which is sufficiently long, and has sufficient homology to both isoamylase-type sequences that expression of both native isoamylase-type genes (if present) is inhibited, or, in the alternative, to ensure that two different sequences are employed to inhibit expression of the respective native isoamylase-type genes. The same comments apply equally to the pullulanase-type sequences discovered by the inventors.
Both pullulanase and isoamylase genes appear to be expressed in tubers and leaves since PCR bands of the correct size can be amplified from either tuber or leaf first strand cDNA templates. The intensity of the amplified band is stronger in tubers for both DBE, possibly indicating that the expression level of both genes is higher in tubers, but this should be confirmed by northern analysis.
References
Ball et al, (1996) Cell 86, 349-352.
Becker et al., (1992) Plant Molecular Biology 20, 1195-1197.
Burton et al, (1995) Plant J. 7, 3-15.
Drummond et al, (1970) FEBS Lett 9, 136-140.
Frohman et al, (1988) Proc. Natl. Acad. Sci. USA 85, 8998-9002.
Gidley (1985) Carbohydrate Research 139, 85-93.
Guerineau et al, (1988) Nucl. Acids Res. 16, 11380.
Ishizaki et al, (1983) Agric. Biol. Chem. 47, 771-779.
James et al, (1995) Plant Cell 7, 417-429.
Jefferson et al, (1987) EMBO J. 6, 3901-3907.
Koømann et α/.,(1995) WO 95/04826.
Koømann et al, (1996) WO 96/19581. Kortsee et al, (1996) The Plant Journal 10, 83-90.
Logemann et al, (1987) Anal. Biochem. 163, 21-26.
Molulle et al, (1996) Plant Cell 8,1353-1366.
Murray & Thompson (1980) Nucl. Acids Res. 8, 4321- 4325.
Nakamura (1996) Plant Science 121, 1-18.
Nakamura et al, (1996) Planta 199, 209-218.
Pan & Nelson (1984) Plant Physiol. 74, 324-328.
Renz et al, (1995) Genbank accession number X83969.
Sambrook et al, (1989) Molecular cloning: A laboratory manual, 2nd ed. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, N.Y.
To nasky & Krisman (1987) Eur. J. Biochem. 168, 393-397.
Takeda et al, (1993) Carbohydrate Research 240, 253-263.
Visser et al, (1989) Plant Sci. 64, 185-192.

Claims

Claims
1. A nucleic acid sequence obtainable from potato plants and carrying at least a portion of an isoamylase-type debranching enzyme (DBE) gene.
2. A sequence according to claim 1, comprising at least 200bp of an isoamylase gene.
3. A sequence according to claim 1 or 2, comprising at least 300-600bp of an isoamylase
4. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 5A and 5B, or a functional equivalent thereof.
5. A sequence according to any one of claims 1, 2 or 3, comprising substantially any one of the nucleic acid sequences shown in Figures 6A, 6B, 7A and 7B, or a functional equivalent thereof.
6. A sequence according to any one of claims 1, 2 or 3 which, when linked in the sense orientation to a promoter, encodes a polypeptide comprising the amino acid sequence shown in Figure 8.
7. A sequence according to claim 6, comprising substantially nucleotides 79-1595 of the nucleic acid sequence shown in Figure 8. or a functional equivalent thereof.
8. A nucleic acid construct comprising a sequence in accordance with any one of the preceding claims operably linked in the sense or antisense orientation to a promoter active in a plant.
9. A host cell into which has been introduced a sequence in accordance with any one of claims 1-7, or a construct in accordance with claim 8.
10. A plant cell according to claim 9.
1 1. A plantlet grown from a plant cell according to claim 10.
12. A method of altering a plant by inhibiting the expression of an isoamylase therein, the method comprising the steps of: introducing into the plant at least 200bp of a sequence carrying- an isoamylase gene and exhibiting at least 80% identity with a nucleic acid sequence shown in any one of Figures 5A, 5B, 6A, 6B, 7A, 7B or 8, said sequence being operably linked in the sense or antisense orientation to a suitable promoter active in the plant; and causing transcription of the introduced nucleic acid sequence, said transcript and/or the translation product thereof being sufficient to interfere with the expression of a homologous isoamylase gene naturally present in the plant.
13. A method according to claim 12, wherein the plant is: potato, sweet potato, maize, wheat, barley, oat, cassava, pea, or rice.
14. A method according to claim 12 or 13, comprising the introduction of one or more additional nucleic acid sequences, operably linked in the sense or anti-sense orientation to a suitable promoter active in the plant, and causing transcription of the one or more additional nucleic acid sequences, said transcript(s) and/or the translation product(s) thereof being sufficient to interfere with the expression of a homologous gene present in the plant.
15. A method according to claim 14, wherein said additional nucleic acid sequence comprises an effective portion of a pullulanase type debranching enzyme.
16. A method according to claim 14 or 15, wherein the said additional nucleic acid sequence comprises a portion which confers a waxy (i.e. low amylose starch) phenotype on the plant.
17. A method according to any one of claims 12-15, wherein the sequences are introduced into a plant having a waxy (i.e. low amylose starch) phenotype.
18. A method according to any one of claims 12-17, wherein the method results in a plant comprising starch having different properties compared to starch from an equivalent, but unaltered plant.
19. A plant altered by the method of any one of claims 12-18, or the progeny thereof.
20. Starch obtained from a plant according to claim 19, having altered properties compared to starch obtained from an equivalent but unaltered plant.
21. Starch according to claim 20. having increased branching and/or shorter chain length compared to starch extracted from an equivalent but unaltered plant.
22. Starch according to claim 19 or 20, having reduced peak viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
23. Starch according to any one of claims 19, 20 or 21, having higher setback viscosity compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
24. Starch according to any one of claims 19-22, having an increased viscosity onset temperature compared to starch extracted from an equivalent but unaltered plant, as determined by analysis of a 7.4% (w/v) starch suspension using a Rapid Visco Analyser series 4 instrument.
25. A nucleic acid sequence substantially as hereinbefore defined and with reference to the accompanying drawings.
26. A method of altering a plant substantially as hereinbefore defined.
PCT/GB1998/002665 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches WO1999012950A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP98941593A EP1009751A2 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches
CA002302639A CA2302639A1 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches
AU89911/98A AU8991198A (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9718863.5A GB9718863D0 (en) 1997-09-06 1997-09-06 Improvements in or relating to stability of plant starches
GB9718863.5 1997-09-06

Publications (3)

Publication Number Publication Date
WO1999012950A2 WO1999012950A2 (en) 1999-03-18
WO1999012950A3 WO1999012950A3 (en) 1999-05-06
WO1999012950A9 true WO1999012950A9 (en) 1999-06-10

Family

ID=10818600

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/002665 WO1999012950A2 (en) 1997-09-06 1998-09-04 Improvements in or relating to stability of plant starches

Country Status (5)

Country Link
EP (1) EP1009751A2 (en)
AU (1) AU8991198A (en)
CA (1) CA2302639A1 (en)
GB (1) GB9718863D0 (en)
WO (1) WO1999012950A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9173394B2 (en) 2007-09-26 2015-11-03 Bayer Intellectual Property Gmbh Active agent combinations having insecticidal and acaricidal properties
US9574201B2 (en) 2010-06-09 2017-02-21 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
US9593317B2 (en) 2010-06-09 2017-03-14 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9716185D0 (en) 1997-07-31 1997-10-08 Innes John Centre Starch debranching enzymes
CL2007003744A1 (en) 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES A 2-PYRIDILMETILBENZAMIDE DERIVATIVE AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
CL2007003743A1 (en) 2006-12-22 2008-07-11 Bayer Cropscience Ag COMPOSITION THAT INCLUDES FENAMIDONA AND AN INSECTICIDE COMPOUND; AND METHOD TO CONTROL FITOPATOGENOS CULTURES AND INSECTS FACING OR PREVENTIVELY.
JP2010520899A (en) 2007-03-12 2010-06-17 バイエル・クロツプサイエンス・アクチエンゲゼルシヤフト Dihalophenoxyphenylamidine and its use as a fungicide
US8080688B2 (en) 2007-03-12 2011-12-20 Bayer Cropscience Ag 3, 4-disubstituted phenoxyphenylamidines and use thereof as fungicides
EP1969934A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG 4-cycloalkyl or 4-aryl substituted phenoxy phenylamidines and their use as fungicides
EP1969929A1 (en) 2007-03-12 2008-09-17 Bayer CropScience AG Substituted phenylamidines and their use as fungicides
EP2136628B1 (en) 2007-03-12 2015-07-01 Bayer Intellectual Property GmbH Phenoxy substituted phenylamidine derivatives and their use as fungicides
EP2146975B1 (en) 2007-04-19 2015-06-17 Bayer Intellectual Property GmbH Thiadiazolyl oxyphenyl amidines and the use thereof as a fungicide
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
DE102007045956A1 (en) 2007-09-26 2009-04-09 Bayer Cropscience Ag Combination of active ingredients with insecticidal and acaricidal properties
DE102007045920B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistic drug combinations
DE102007045953B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
EP2090168A1 (en) 2008-02-12 2009-08-19 Bayer CropScience AG Method for improving plant growth
EP2072506A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Thiazolyloxyphenylamidine or thiadiazolyloxyphenylamidine und its use as fungicide
EP2168434A1 (en) 2008-08-02 2010-03-31 Bayer CropScience AG Use of azols to increase resistance of plants of parts of plants to abiotic stress
AU2009281457A1 (en) 2008-08-14 2010-02-18 Bayer Cropscience Ag Insecticidal 4-phenyl-1H-pyrazoles
DE102008041695A1 (en) 2008-08-29 2010-03-04 Bayer Cropscience Ag Methods for improving plant growth
EP2201838A1 (en) 2008-12-05 2010-06-30 Bayer CropScience AG Active ingredient-beneficial organism combinations with insecticide and acaricide properties
EP2198709A1 (en) 2008-12-19 2010-06-23 Bayer CropScience AG Method for treating resistant animal pests
US9763451B2 (en) 2008-12-29 2017-09-19 Bayer Intellectual Property Gmbh Method for improved use of the production potential of genetically modified plants
EP2223602A1 (en) 2009-02-23 2010-09-01 Bayer CropScience AG Method for improved utilisation of the production potential of genetically modified plants
EP2204094A1 (en) 2008-12-29 2010-07-07 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants Introduction
EP2039771A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
EP2039772A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants introduction
EP2039770A2 (en) 2009-01-06 2009-03-25 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
US8487118B2 (en) 2009-01-19 2013-07-16 Bayer Cropscience Ag Cyclic diones and their use as insecticides, acaricides and/or fungicides
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
JP5592398B2 (en) 2009-01-28 2014-09-17 バイエル・クロップサイエンス・アーゲー Disinfectant N-cycloalkyl-N-bicyclic methylene-carboxamide derivatives
AR075126A1 (en) 2009-01-29 2011-03-09 Bayer Cropscience Ag METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL
WO2010094666A2 (en) 2009-02-17 2010-08-26 Bayer Cropscience Ag Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
EP2218717A1 (en) 2009-02-17 2010-08-18 Bayer CropScience AG Fungicidal N-((HET)Arylethyl)thiocarboxamide derivatives
TW201031331A (en) 2009-02-19 2010-09-01 Bayer Cropscience Ag Pesticide composition comprising a tetrazolyloxime derivative and a fungicide or an insecticide active substance
EP2410849A1 (en) 2009-03-25 2012-02-01 Bayer CropScience AG Active ingredient combinations having insecticidal and acaricidal properties
EP2232995A1 (en) 2009-03-25 2010-09-29 Bayer CropScience AG Method for improved utilisation of the production potential of transgenic plants
US8828906B2 (en) 2009-03-25 2014-09-09 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8846567B2 (en) 2009-03-25 2014-09-30 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
UA104887C2 (en) 2009-03-25 2014-03-25 Баєр Кропсаєнс Аг Synergic combinations of active ingredients
MX2011009830A (en) 2009-03-25 2011-10-06 Bayer Cropscience Ag Active ingredient combinations with insecticidal and acaricidal properties.
EP2239331A1 (en) 2009-04-07 2010-10-13 Bayer CropScience AG Method for improved utilization of the production potential of transgenic plants
BRPI1015543A8 (en) 2009-05-06 2016-05-24 Bayer Cropscience Ag CYCLOPENTANEDIONE COMPOUNDS AND THEIR USE AS INSECTICIDES, ACARICIDES AND/OR FUNGICIDES.
AR076839A1 (en) 2009-05-15 2011-07-13 Bayer Cropscience Ag FUNGICIDE DERIVATIVES OF PIRAZOL CARBOXAMIDAS
EP2251331A1 (en) 2009-05-15 2010-11-17 Bayer CropScience AG Fungicide pyrazole carboxamides derivatives
EP2255626A1 (en) 2009-05-27 2010-12-01 Bayer CropScience AG Use of succinate dehydrogenase inhibitors to increase resistance of plants or parts of plants to abiotic stress
PL2437595T3 (en) 2009-06-02 2019-05-31 Bayer Cropscience Ag Use of fluopyram for controlling sclerotinia ssp
EP2453750A2 (en) 2009-07-16 2012-05-23 Bayer CropScience AG Synergistic active substance combinations containing phenyl triazoles
WO2011015524A2 (en) 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
EP2292094A1 (en) 2009-09-02 2011-03-09 Bayer CropScience AG Active compound combinations
EP2343280A1 (en) 2009-12-10 2011-07-13 Bayer CropScience AG Fungicide quinoline derivatives
WO2011080256A1 (en) 2009-12-28 2011-07-07 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
JP5894928B2 (en) 2009-12-28 2016-03-30 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Fungicide hydroxymoyl-heterocyclic derivative
BR112012012340A2 (en) 2009-12-28 2015-09-08 Bayer Cropscience Ag compost, fungicidal composition and method for the control of plant pathogenic fungus
BR112012018108A2 (en) 2010-01-22 2015-10-20 Bayer Ip Gmbh acaricidal and / or insecticidal combinations of active ingredients
US20110218103A1 (en) 2010-03-04 2011-09-08 Bayer Cropscience Ag Fluoroalkyl-substituted 2-amidobenzimidazoles
BR112012025714A2 (en) 2010-04-06 2015-09-08 Bayer Ip Gmbh use of 4-phenylbutyric acid and / or salts thereof to increase plant stress tolerance
CA2795838A1 (en) 2010-04-09 2011-10-13 Bayer Intellectual Property Gmbh Use of derivatives of the(1-cyanocyclopropyl)phenylphosphinic acid, the esters thereof and/or the salts thereof for enhancing the tolerance of plants to abiotic stress
JP2013525401A (en) 2010-04-28 2013-06-20 バイエル・クロップサイエンス・アーゲー Fungicide hydroxymoyl-heterocyclic derivative
WO2011134912A1 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-heterocycles derivatives
WO2011134911A2 (en) 2010-04-28 2011-11-03 Bayer Cropscience Ag Fungicide hydroximoyl-tetrazole derivatives
JP5730992B2 (en) 2010-06-03 2015-06-10 バイエル・クロップサイエンス・アーゲーBayer Cropscience Ag N-[(Heta) arylethyl)] pyrazole (thio) carboxamides and their hetero-substituted analogues
CN102918028B (en) 2010-06-03 2016-04-27 拜尔农科股份公司 N-[(mixing) arylalkyl] pyrazoles (sulfo-) carboxylic acid amides and the assorted analogue replaced thereof
UA110703C2 (en) 2010-06-03 2016-02-10 Байєр Кропсайнс Аг Fungicidal n-[(trisubstitutedsilyl)methyl]carboxamide
WO2012010579A2 (en) 2010-07-20 2012-01-26 Bayer Cropscience Ag Benzocycloalkenes as antifungal agents
PL2611300T3 (en) 2010-09-03 2016-10-31 Substituted annelated dihydropyrimidinone compounds
AU2011306889C1 (en) 2010-09-22 2015-11-19 Bayer Cropscience Aktiengesellschaft Use of active ingredients for controlling nematodes in nematode-resistant crops
EP2460406A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Use of fluopyram for controlling nematodes in nematode resistant crops
WO2012045798A1 (en) 2010-10-07 2012-04-12 Bayer Cropscience Ag Fungicide composition comprising a tetrazolyloxime derivative and a thiazolylpiperidine derivative
EP2630125B1 (en) 2010-10-21 2016-08-24 Bayer Intellectual Property GmbH N-benzyl heterocyclic carboxamides
JP2013541553A (en) 2010-10-21 2013-11-14 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー 1- (Heterocycliccarbonyl) piperidines
CA2815117A1 (en) 2010-11-02 2012-05-10 Bayer Intellectual Property Gmbh N-hetarylmethyl pyrazolylcarboxamides
MX2013005410A (en) 2010-11-15 2013-07-03 Bayer Ip Gmbh 5-halogenopyrazole(thio)carboxamides.
WO2012065944A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag N-aryl pyrazole(thio)carboxamides
WO2012065947A1 (en) 2010-11-15 2012-05-24 Bayer Cropscience Ag 5-halogenopyrazolecarboxamides
MX2013005356A (en) 2010-12-01 2013-07-05 Bayer Ip Gmbh Use of fluopyram for controlling nematodes in crops and for increasing yield.
EP2460407A1 (en) 2010-12-01 2012-06-06 Bayer CropScience AG Agent combinations comprising pyridylethyl benzamides and other agents
EP2474542A1 (en) 2010-12-29 2012-07-11 Bayer CropScience AG Fungicide hydroximoyl-tetrazole derivatives
JP2014502611A (en) 2010-12-29 2014-02-03 バイエル・インテレクチユアル・プロパテイー・ゲー・エム・ベー・ハー Fungicide hydroxymoyl-tetrazole derivative
EP2471363A1 (en) 2010-12-30 2012-07-04 Bayer CropScience AG Use of aryl-, heteroaryl- and benzylsulfonamide carboxylic acids, -carboxylic acid esters, -carboxylic acid amides and -carbonitriles and/or its salts for increasing stress tolerance in plants
EP2494867A1 (en) 2011-03-01 2012-09-05 Bayer CropScience AG Halogen-substituted compounds in combination with fungicides
US20130345058A1 (en) 2011-03-10 2013-12-26 Wolfram Andersch Use of lipochito-oligosaccharide compounds for safeguarding seed safety of treated seeds
CN103502238A (en) 2011-03-14 2014-01-08 拜耳知识产权有限责任公司 Fungicide hydroximoyl-tetrazole derivatives
US20140051575A1 (en) 2011-04-08 2014-02-20 Juergen Benting Fungicide hydroximoyl-tetrazole derivatives
AR090010A1 (en) 2011-04-15 2014-10-15 Bayer Cropscience Ag 5- (CICLOHEX-2-EN-1-IL) -PENTA-2,4-DIENOS AND 5- (CICLOHEX-2-EN-1-IL) -PENT-2-EN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST THE ABIOTIC STRESS OF PLANTS, USES AND TREATMENT METHODS
AR085568A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENTA-2,4-DIENOS AND 5- (BICYCLE [4.1.0] HEPT-3-EN-2-IL) -PENT- 2-IN-4-INOS REPLACED AS ACTIVE PRINCIPLES AGAINST ABIOTIC STRESS OF PLANTS
AR085585A1 (en) 2011-04-15 2013-10-09 Bayer Cropscience Ag VINIL- AND ALQUINILCICLOHEXANOLES SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST STRIPS ABIOTIQUE OF PLANTS
EP2511255A1 (en) 2011-04-15 2012-10-17 Bayer CropScience AG Substituted prop-2-in-1-ol and prop-2-en-1-ol derivatives
ES2714714T3 (en) 2011-04-22 2019-05-29 Bayer Cropscience Ag Compositions of active compounds comprising a (thio) carboximide derivative and a fungicidal compound
AU2012266597B2 (en) 2011-06-06 2016-09-22 Bayer Cropscience Nv Methods and means to modify a plant genome at a preselected site
EP2729007A1 (en) 2011-07-04 2014-05-14 Bayer Intellectual Property GmbH Use of substituted isoquinolinones, isoquinolindiones, isoquinolintriones and dihydroisoquinolinones or in each case salts thereof as active agents against abiotic stress in plants
BR112014002855A2 (en) 2011-08-10 2017-02-21 Bayer Ip Gmbh active compound combinations including specific tetramic acid derivatives
US20140206726A1 (en) 2011-08-22 2014-07-24 Juergen Benting Fungicide hydroximoyl-tetrazole derivatives
WO2013026740A2 (en) 2011-08-22 2013-02-28 Bayer Cropscience Nv Methods and means to modify a plant genome
EP2561759A1 (en) 2011-08-26 2013-02-27 Bayer Cropscience AG Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
US20140221210A1 (en) 2011-09-09 2014-08-07 Peter Dahmen Acyl-homoserine lactone derivatives for improving plant yield
JP6002225B2 (en) 2011-09-12 2016-10-05 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH Bactericidal 4-substituted-3- {phenyl [(heterocyclylmethoxy) imino] methyl} -1,2,4-oxadiazol-5 (4H) -one derivatives
AR087874A1 (en) 2011-09-16 2014-04-23 Bayer Ip Gmbh USE OF ACILSULPHONAMIDES TO IMPROVE THE PERFORMANCE OF PLANTS
CA2848622A1 (en) 2011-09-16 2013-03-21 Bayer Intellectual Property Gmbh Use of 5-phenyl- or 5-benzyl-2-isoxazoline-3-carboxylates for improving plant yield
AR087873A1 (en) 2011-09-16 2014-04-23 Bayer Ip Gmbh USE OF PHENYLPIRAZOLIN-3-CARBOXYLATES TO IMPROVE PLANT PERFORMANCE
AR087971A1 (en) 2011-09-23 2014-04-30 Bayer Ip Gmbh USE OF ACID DERIVATIVES 1-PHENYL-PIRAZOL-3-CARBOXILIC 4-SUBSTITUTED AS ACTIVE PRINCIPLES AGAINST PLANTS ABIOTIC STRESS
CN103842507A (en) 2011-10-04 2014-06-04 拜耳知识产权有限责任公司 Rnai for the control of fungi and oomycetes by inhibiting saccharopine dehydrogenase gene
WO2013050324A1 (en) 2011-10-06 2013-04-11 Bayer Intellectual Property Gmbh Combination, containing 4-phenylbutyric acid (4-pba) or a salt thereof (component (a)) and one or more selected additional agronomically active compounds (component(s) (b)), that reduces abiotic plant stress
MX2014005976A (en) 2011-11-21 2014-08-27 Bayer Ip Gmbh Fungicide n-[(trisubstitutedsilyl)methyl]-carboxamide derivatives.
CN105906567B (en) 2011-11-30 2019-01-22 拜耳知识产权有限责任公司 Antifungal N- bicyclic alkyl and N- tricyclic alkyl (thio) carboxamide derivative
WO2013092519A1 (en) 2011-12-19 2013-06-27 Bayer Cropscience Ag Use of anthranilic acid diamide derivatives for pest control in transgenic crops
KR102028893B1 (en) 2011-12-29 2019-10-07 바이엘 인텔렉쳐 프로퍼티 게엠베하 Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
KR102028903B1 (en) 2011-12-29 2019-10-07 바이엘 인텔렉쳐 프로퍼티 게엠베하 Fungicidal 3-[(pyridin-2-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
CN104244714B (en) 2012-02-22 2018-02-06 拜耳农作物科学股份公司 Succinate dehydrogenase inhibitors (SDHI) are used for the purposes for preventing and treating the timber disease in grape
BR122019010667B1 (en) 2012-02-27 2020-12-22 Bayer Intellectual Property Gmbh combination, method to control harmful phytopathogenic fungi and use of said combination
WO2013139949A1 (en) 2012-03-23 2013-09-26 Bayer Intellectual Property Gmbh Compositions comprising a strigolactame compound for enhanced plant growth and yield
EP2836489B1 (en) 2012-04-12 2016-06-29 Bayer Cropscience AG N-acyl-2-(cyclo) alkylpyrrolidines and piperidines useful as fungicides
WO2013156560A1 (en) 2012-04-20 2013-10-24 Bayer Cropscience Ag N-cycloalkyl-n-[(trisubstitutedsilylphenyl)methylene]-(thio)carboxamide derivatives
CA2865599C (en) 2012-04-20 2020-10-27 Bayer Cropscience Ag N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
WO2013160230A1 (en) 2012-04-23 2013-10-31 Bayer Cropscience Nv Targeted genome engineering in plants
EP2847171A1 (en) 2012-05-09 2015-03-18 Bayer CropScience AG 5-halogenopyrazole indanyl carboxamides
EP2662370A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole benzofuranyl carboxamides
EP2662360A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole indanyl carboxamides
US9249104B2 (en) 2012-05-09 2016-02-02 Bayer Cropscience Ag Pyrazole indanyl carboxamides
EP2662364A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole tetrahydronaphthyl carboxamides
EP2662363A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG 5-Halogenopyrazole biphenylcarboxamides
EP2662362A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazole indanyl carboxamides
EP2662361A1 (en) 2012-05-09 2013-11-13 Bayer CropScience AG Pyrazol indanyl carboxamides
AR091104A1 (en) 2012-05-22 2015-01-14 Bayer Cropscience Ag COMBINATIONS OF ACTIVE COMPOUNDS THAT INCLUDE A LIPO-CHYTOOLIGOSACARIDE DERIVATIVE AND A NEMATICIDE, INSECTICIDE OR FUNGICIDE COMPOUND
AU2013289301A1 (en) 2012-07-11 2015-01-22 Bayer Cropscience Ag Use of fungicidal combinations for increasing the tolerance of a plant towards abiotic stress
JP2015532650A (en) 2012-09-05 2015-11-12 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Use of substituted 2-amidobenzimidazoles, 2-amidobenzoxazoles and 2-amidobenzothiazoles or their salts as active substances against abiotic plant stress
EP2908640B1 (en) 2012-10-19 2019-10-02 Bayer Cropscience AG Method of plant growth promotion using carboxamide derivatives
ES2665320T3 (en) 2012-10-19 2018-04-25 Bayer Cropscience Ag Method of treating fungicide resistant plants against fungi using carboxamide or thiocarboxamide derivatives
UA114822C2 (en) 2012-10-19 2017-08-10 Байєр Кропсайнс Аг Active compound combinations comprising carboxamide derivatives
US20150250176A1 (en) 2012-10-19 2015-09-10 Bayer Cropscience Ag Method for enhancing tolerance to abiotic stress in plants using carboxamide or thiocarboxamide derivatives
WO2014079957A1 (en) 2012-11-23 2014-05-30 Bayer Cropscience Ag Selective inhibition of ethylene signal transduction
EP2735231A1 (en) 2012-11-23 2014-05-28 Bayer CropScience AG Active compound combinations
BR112015012054A2 (en) 2012-11-30 2017-07-11 Bayer Cropscience Ag fungicide or binary pesticide mixture
EA030235B1 (en) 2012-11-30 2018-07-31 Байер Кропсайенс Акциенгезельшафт Ternary fungicidal mixtures
UA117819C2 (en) 2012-11-30 2018-10-10 Байєр Кропсайєнс Акцієнгезелльшафт Binary pesticidal and fungicidal mixtures
BR112015012519A2 (en) 2012-11-30 2017-07-11 Bayer Cropscience Ag ternary mixtures fungicides and pesticides
CN104812247A (en) 2012-11-30 2015-07-29 拜耳作物科学股份公司 Binary fungicidal mixtures
EP2740356A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted (2Z)-5(1-Hydroxycyclohexyl)pent-2-en-4-inic acid derivatives
EP2740720A1 (en) 2012-12-05 2014-06-11 Bayer CropScience AG Substituted bicyclic and tricyclic pent-2-en-4-inic acid derivatives and their use for enhancing the stress tolerance in plants
US20150305334A1 (en) 2012-12-05 2015-10-29 Bayer Cropscience Ag Use of substituted 1-(aryl ethynyl)-, 1-(heteroaryl ethynyl)-, 1-(heterocyclyl ethynyl)- and 1-(cycloalkenyl ethynyl)-cyclohexanols as active agents against abiotic plant stress
WO2014090765A1 (en) 2012-12-12 2014-06-19 Bayer Cropscience Ag Use of 1-[2-fluoro-4-methyl-5-(2,2,2-trifluoroethylsulfinyl)phenyl]-5-amino-3-trifluoromethyl)-1 h-1,2,4 tfia zole for controlling nematodes in nematode-resistant crops
AR093996A1 (en) 2012-12-18 2015-07-01 Bayer Cropscience Ag BACTERICIDAL COMBINATIONS AND BINARY FUNGICIDES
IN2015DN04206A (en) 2012-12-19 2015-10-16 Bayer Cropscience Ag
TW201446759A (en) 2013-03-07 2014-12-16 Bayer Cropscience Ag Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
CN105121650A (en) 2013-04-02 2015-12-02 拜尔作物科学公司 Targeted genome engineering in eukaryotes
EA028812B1 (en) 2013-04-12 2018-01-31 Байер Кропсайенс Акциенгезельшафт Triazole derivatives
WO2014167008A1 (en) 2013-04-12 2014-10-16 Bayer Cropscience Ag Novel triazolinthione derivatives
WO2014170345A2 (en) 2013-04-19 2014-10-23 Bayer Cropscience Ag Method for improved utilization of the production potential of transgenic plants
CN105307492B (en) 2013-04-19 2018-03-30 拜耳作物科学股份公司 Binary desinsection or deinsectization mixture
WO2014177514A1 (en) 2013-04-30 2014-11-06 Bayer Cropscience Ag Nematicidal n-substituted phenethylcarboxamides
TW201507722A (en) 2013-04-30 2015-03-01 Bayer Cropscience Ag N-(2-halogen-2-phenethyl)carboxamides as nematicides and endoparasiticides
EP3013802B1 (en) 2013-06-26 2019-08-14 Bayer Cropscience AG N-cycloalkyl-n-[(bicyclylphenyl)methylene]-(thio)carboxamide derivatives
MX2016000141A (en) 2013-07-09 2016-03-01 Bayer Cropscience Ag Use of selected pyridone carboxamides or salts thereof as active substances against abiotic plant stress.
RU2685723C1 (en) 2013-12-05 2019-04-23 Байер Кропсайенс Акциенгезелльшафт N-cycloalkyl-n-{[2-(1-substituted cycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
US10071967B2 (en) 2013-12-05 2018-09-11 Bayer Cropscience Aktiengesellschaft N-cycloalkyl-N-{[2-(1-substitutedcycloalkyl)phenyl]methylene}-(thio)carboxamide derivatives
AR101214A1 (en) 2014-07-22 2016-11-30 Bayer Cropscience Ag CIANO-CICLOALQUILPENTA-2,4-DIENOS, CIANO-CICLOALQUILPENT-2-EN-4-INAS, CIANO-HETEROCICLILPENTA-2,4-DIENOS AND CYANO-HETEROCICLILPENT-2-EN-4-INAS REPLACED AS ACTIVE PRINCIPLES PLANTS ABIOTIC
AR103024A1 (en) 2014-12-18 2017-04-12 Bayer Cropscience Ag SELECTED PYRIDONCARBOXAMIDS OR ITS SALTS AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANTS STRESS
EP3283476B1 (en) 2015-04-13 2019-08-14 Bayer Cropscience AG N-cycloalkyl-n-(biheterocyclyethylene)-(thio)carboxamide derivatives
CA3012607A1 (en) 2015-06-18 2016-12-22 The Broad Institute Inc. Crispr enzymes and systems
RU2019104918A (en) 2016-07-29 2020-08-28 Байер Кропсайенс Акциенгезельшафт COMBINATIONS OF ACTIVE COMPOUNDS AND METHODS FOR PROTECTING PLANT REPRODUCTION MATERIAL
WO2018054832A1 (en) 2016-09-22 2018-03-29 Bayer Cropscience Aktiengesellschaft Novel triazole derivatives
EP3515906A1 (en) 2016-09-22 2019-07-31 Bayer CropScience Aktiengesellschaft Novel triazole derivatives and their use as fungicides
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
AU2017351474A1 (en) 2016-10-26 2019-04-18 Bayer Cropscience Aktiengesellschaft Use of pyraziflumid for controlling Sclerotinia spp in seed treatment applications
RU2755433C2 (en) 2016-12-08 2021-09-16 Байер Кропсайенс Акциенгезельшафт Use of insecticides to combat wireworms
EP3332645A1 (en) 2016-12-12 2018-06-13 Bayer Cropscience AG Use of substituted pyrimidine diones or their salts as agents to combat abiotic plant stress
WO2018108627A1 (en) 2016-12-12 2018-06-21 Bayer Cropscience Aktiengesellschaft Use of substituted indolinylmethyl sulfonamides, or the salts thereof for increasing the stress tolerance of plants
WO2018204777A2 (en) 2017-05-05 2018-11-08 The Broad Institute, Inc. Methods for identification and modification of lncrna associated with target genotypes and phenotypes
WO2019025153A1 (en) 2017-07-31 2019-02-07 Bayer Cropscience Aktiengesellschaft Use of substituted n-sulfonyl-n'-aryl diaminoalkanes and n-sulfonyl-n'-heteroaryl diaminoalkanes or salts thereof for increasing the stress tolerance in plants
EP3684397A4 (en) 2017-09-21 2021-08-18 The Broad Institute, Inc. Systems, methods, and compositions for targeted nucleic acid editing
US10968257B2 (en) 2018-04-03 2021-04-06 The Broad Institute, Inc. Target recognition motifs and uses thereof
JP2021525774A (en) 2018-06-04 2021-09-27 バイエル アクチェンゲゼルシャフトBayer Aktiengesellschaft Herbicidal active bicyclic benzoylpyrazole
EP3898958A1 (en) 2018-12-17 2021-10-27 The Broad Institute, Inc. Crispr-associated transposase systems and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004826A1 (en) * 1993-08-09 1995-02-16 Institut Für Genbiologische Forschung Berlin Gmbh Debranching enzymes and dna sequences coding them, suitable for changing the degree of branching of amylopectin starch in plants
US5750876A (en) * 1994-07-28 1998-05-12 Monsanto Company Isoamylase gene, compositions containing it, and methods of using isoamylases
DE4447387A1 (en) * 1994-12-22 1996-06-27 Inst Genbiologische Forschung Debranching enzymes from plants and DNA sequences encoding these enzymes
DE19618125A1 (en) * 1996-05-06 1997-11-13 Planttec Biotechnologie Gmbh Nucleic acid molecules that encode new potato debranching enzymes
GB9716185D0 (en) * 1997-07-31 1997-10-08 Innes John Centre Starch debranching enzymes

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9173394B2 (en) 2007-09-26 2015-11-03 Bayer Intellectual Property Gmbh Active agent combinations having insecticidal and acaricidal properties
US9574201B2 (en) 2010-06-09 2017-02-21 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
US9593317B2 (en) 2010-06-09 2017-03-14 Bayer Cropscience Nv Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering

Also Published As

Publication number Publication date
WO1999012950A3 (en) 1999-05-06
EP1009751A2 (en) 2000-06-21
WO1999012950A2 (en) 1999-03-18
GB9718863D0 (en) 1997-11-12
CA2302639A1 (en) 1999-03-18
AU8991198A (en) 1999-03-29

Similar Documents

Publication Publication Date Title
WO1999012950A9 (en) Improvements in or relating to stability of plant starches
US6956148B1 (en) Nucleic acids from cassava encoding starch branching enzyme II (SBEII) and their use
US6784338B1 (en) Genetically engineered modification of potato to form amylopectin-type starch
AU724942B2 (en) Transgenic potatoes having reduced levels of alpha glucan L- or H-type tuber phosphorylase activity with reduced cold-sweetening
Woolley et al. Purification and properties of an endo-β-1, 4-glucanase from strawberry and down-regulation of the corresponding gene, cel1
US7153674B2 (en) Nucleic acid molecules encoding enzymes having fructosyl polymerase activity
US6570066B1 (en) Nucleotide sequences encoding enzymes that alter the carbohydrate concentration and composition in plants
EP0719338B1 (en) Combination of dna sequences which enable the formation of modified starch in plant cells and plants, processes for the production of these plants
EP0479359B1 (en) Methods for producing transgenic plants having a modified carbohydrate content
US5750876A (en) Isoamylase gene, compositions containing it, and methods of using isoamylases
Wang et al. The essential role of GhPEL gene, encoding a pectate lyase, in cell wall loosening by depolymerization of the de-esterified pectin during fiber elongation in cotton
JP2002518015A (en) Improvement of or related to plants and plant products
EP0563201A1 (en) Genetically engineered modification of potato to form amylose-type starch
US5705375A (en) Transgenic plants having a modified carbohydrate content
CA2136828A1 (en) Dna sequences and plasmids for the preparation of plants with changed sucrose concentration
US5767364A (en) Endo-1,4-beta-D-glucanase
HUT73468A (en) Method of improving the quality of stored potatoes
US5856467A (en) Genetically engineered modification of potato to form amylose-type starch
WO1996012812A1 (en) A method of reducing the level of sugar in an organism
US5569829A (en) Transformed tomato plants
CZ258799A3 (en) Potato plant exhibiting enhanced storage characteristics at low temperature and method of improving those characteristics

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C2

Designated state(s): AU CA US

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

COP Corrected version of pamphlet

Free format text: PAGES 1-18, SEQUENCE LISTING, ADDED

WWE Wipo information: entry into national phase

Ref document number: 1998941593

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 89911/98

Country of ref document: AU

ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2302639

Kind code of ref document: A

Format of ref document f/p: F

Ref document number: 2302639

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1998941593

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1998941593

Country of ref document: EP